Objective The aim of this study was to investigate the relationship between antineutrophil cytoplasmic antibodies (ANCA) ...

Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has ...

María Magdalena Guzmán Garza, better known as Magda Guzmán, was a renowned Mexican actress born on May 16, 1931, in Saltillo, ...

After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...

Implementing an Electrocardiogram Suite in the Emergency Department to Decrease Door-to-EKG Time ...

When signing up for insurance, people often worry whether they will receive sufficient insurance payouts when truly needed.

Biolexis Therapeutics Inc. has identified glucagon-like peptide 1 receptor (GLP-1R) agonists potentially useful for the treatment of diabetes, obesity, stroke, myocardial infarction, renal failure, ...

During the 2026 J.P. Morgan Healthcare Conference (JPM), the 2026 China FIC Innovation & Collaboration Summit was successfully held in San Francisco, the United States. Organized by the ZFIC Alliance, ...

Events picked up with the Fourth Universal Definition of MI were tied to higher mortality, emphasizing the role of ancillary ...

Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.

Find out more about how loss of Y chromosome in ageing males was linked to higher heart attack risk in a large prospective ...